Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease

The optimal dosage of cefoperazone-sulbactam for patients with chronic kidney disease (CKD) remains unclear. This study aimed to investigate two treatment strategies of cefoperazone-sulbactam–2 g/2 g twice daily and adjusted dose according to renal function for patients with CKD. A total of 155 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Chien-Ming, Lai, Chih-Cheng, Lee, Chen-Hsiang, Tang, Hung-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137919/
https://www.ncbi.nlm.nih.gov/pubmed/35625254
http://dx.doi.org/10.3390/antibiotics11050610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137919/
https://www.ncbi.nlm.nih.gov/pubmed/35625254
http://dx.doi.org/10.3390/antibiotics11050610

Ejemplares similares